Skip to main content
Cambridge, UK, – 17 December 2019: Abcam plc, a global innovator in life science reagents and tools, and SomaServe Ltd, a Pharma service and specialist reagent business exploiting PolyNautâ Technology, have announced a partnership to commercialise the cell delivery potential of the polymer-based ‘bionic’ nanoparticles, which can carry a range of payloads directly to live cells. Dr Fran Crawford, CEO, SomaServe, commented: “Abcam’s reputation as an innovator in the field of biological reagents and dedicated global commercialisation infrastructure, coupled with their transparent and collegiate…
Westbury, NY – Dec. 16, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today launched its Next-generation Sequencing (NGS) Service, which combines the company’s expertise in human tissue procurement, specimen selection, sample preparation and project management with its in-house NGS capabilities. BioIVT now offers both standard and custom NGS services, including sample extraction, library preparation, sequencing and bioinformatics. “We are excited to launch our NGS Service to support researchers investigating the human genome to…
The UK Innovation Corridor has a unique ecosystem of talent and commerce, with world-class businesses, universities and R&D centres standing firmly on a heritage of ground-breaking discovery and invention, as shown by a new report released today at the Genesis Conference by the London Stansted Cambridge Consortium. This makes it the perfect place to start and build an innovation company and invest in place-making. Three dynamic factors have led to continued investment and start-ups by innovative technology-based companies, as well as significant commercial real estate investments in…
Start Codon cohort companies to receive One Nucleus membership benefits CAMBRIDGE, UK, 11 December 2019 – Start Codon, a new model of life science and healthcare business accelerator, today announced it has partnered with One Nucleus, a membership organisation for life science and healthcare companies. Under the terms of the partnership agreement, One Nucleus will support and profile the life science and healthcare start-ups participating in the Start Codon accelerator programme. Founded in April 2019, Start Codon aims to identify and recruit high potential life science and healthcare…
Cambridge UK, 11 December 2019: Abcam has been honoured with a Glassdoor Employees’ Choice Award, recognising the Best Places to Work in 2020. Abcam is ranked 6th in Glassdoor’s Best Places to Work UK list. The Employees’ Choice Awards are based solely on the input of employees who elect to provide feedback on their jobs, work environments and companies on Glassdoor, one of the world’s largest job and recruiting sites. Alan Hirzel, CEO, Abcam, commented “I’m delighted that our people have rated Abcam as one of the best places to work. As we continue to grow, we want to attract and retain the…
Events showcasing the latest products and innovations for lab professionals spans seven countries LOUGHBOROUGH, England (Dec. 9, 2019) – Activate Science, an annual event series organised by Thermo Fisher Scientific and attended by laboratory personnel across Europe, reached delegates at 29 customer sites in 2019.Emily Quinton, European Marketing Communications Manager, commented: “Activate Science has touched nearly 2,500 delegates stretching over seven European countries this year and provides a valuable opportunity to network and experience the latest innovations in laboratory products…
Cambridge, UK, December 10 2019: Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced it has joined the EU-funded Exposome Project for Health and Occupational Research (EPHOR). The consortium aims to further elucidate the complex relationships between environment and disease by developing the concept of the ‘working-life exposome’, which takes into account all occupational and related non-occupational exposures (e.g. lifestyle) throughout the lifespan of an individual. Owlstone Medical will receive funding…
AMSBIO reports on the pioneering research published** by scientists at Stanford University Medical School that has cited Mimetix® aligned 3D cell culture scaffold supplied by the company to understand the architecture of the myelin sheaths which insulate neuronal axons, so they can transmit electrical impulses quickly and efficiently.Oligodendrocyte cells in the central nervous system can contact up to 50 axon segments per cell to form such myelin sheaths. Meng-Meng Fu of Stanford University and co-authors cultured oligodendrocytes in 3D in vitro on Mimetix® aligned 3D…
ScreenIn3D, a partner of AMSBIO, has been awarded the prestigious ELRIG Prize for Innovation in Drug Discovery at their flagship conference Drug Discovery 2019 which recently took place in Liverpool, UK.ELRIG Drug Discovery has become the largest meeting of life sciences industry professionals in the UK. The 2-day event brings together more than 1200 delegates and over 100 exhibiting companies from around the world to highlight the latest ground-breaking research, discuss cutting-edge advances in the application of laboratory technology to understand disease biology and to identify novel…
Cambridge, UK and Moscow, Russia, 09 December 2019: IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, has been informed that International Biotechnology Center (IBC) Generium, a leading Russian biopharmaceutical company, focused on developing and commercialising pharmaceutical products for the treatment of orphan diseases and cancer, has received approval from the Russian Health Authorities to initiate clinical trials with its CD3/CD19 bispecific antibody for the treatment of B-Cell Acute Lymphoblastic Leukemia (ALL). This is the first IBC Generium…